Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma

Clinical trial NCT00722930 · UNKNOWN

Trial details

NCT number: NCT00722930
Sponsor: Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2008-04-01
Primary completion: 2011-04-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.